These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2007-005100-41||Phase I/II/III Pharmacokinetic and outcome study of Inspiration`s Recombinant Factor IX product, IB1001, in subjects with Hemophilia B||not-yet-due|
|Not reported||2010-024190-39||Study of Recombinant Factor IX Product, IB1001, in Previously Treated Pediatric Subjects with Hemophilia B||2016-12-31||due-trials|